Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Nanostics & OncoHelix — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Nanostics and OncoHelix Partner to Provide ClarityDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the Middle East

Sep 26, 2024•over 1 year ago

Contract Type

partnership

BaltimoreBiotechnologyHealth CareHealth Diagnostics

Description

Nanostics Inc. and OncoHelix have announced their partnership to provide ClarityDX Prostate to healthcare providers and men in the Middle East. ClarityDX Prostate uses biological data, clinical information, and AI-powered learning models to generate a risk score for aggressive prostate cancer, providing critical support in making more informed decisions about further medical procedures.

Company Information

Company

Nanostics & OncoHelix

Location

Baltimore, Maryland, United States

About

Nanostics Inc. is a precision health company developing diagnostic tests with its ClarityDX® platform technology. OncoHelix is a leader in precision diagnostics providing advanced molecular diagnostics and immune profile testing to the Middle East and North Africa (MENA) region through OncoHelix-coLAB.

Predictive Intelligence
Strategic

ML-powered predictions for Nanostics & OncoHelix's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months